[EN] UII-MODULATING COMPOUNDS AND THEIR USE<br/>[FR] COMPOSÉS MODULANT U II ET LEUR UTILISATION
申请人:ACADIA PHARM INC
公开号:WO2008057543A2
公开(公告)日:2008-05-15
[EN] Disclosed herein are novel aromatic-containing compounds and methods for using various aromatic-containing compounds for treatment and prevention of diseases and disorders related to the Urotensin II receptor. [FR] La présente invention concerne de nouveaux composés contenant un groupe aromatique et des procédés permettant d'utiliser divers composés contenant un groupe aromatique pour le traitement et la prévention de maladies et de troubles associés au récepteur de l'urotensine II.
Novel and potent small-molecule urotensin II receptor agonists
作者:Fredrik Lehmann、Erika A. Currier、Bryan Clemons、Lars K. Hansen、Roger Olsson、Uli Hacksell、Kristina Luthman
DOI:10.1016/j.bmc.2009.04.062
日期:2009.7
A series of analogs of the non-peptidic urotensin II receptor agonist N-[1-(4-chlorophenyl)-3-(dimethylamino)propyl]-4-phenylbenzamide (FL104) has been synthesized and evaluated pharmacologically. The enantiomers of the two most potent racemic analogues were obtained from the corresponding diastereomeric mandelic amides. In agreement with previously observed SAR, most of the agonist potency resided